Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIOVIE INC.BIVI · Entity 7702 | Director | August 28, 2026 | August 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIOVIE INC.
Report date August 28, 2026 · Filed August 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 727 |
Reported balance
After 2026-08-28 transaction · row 1
1 source rowRow 1 · 2026-08-28 · Purchase · Acquired 727 · Balance 727 F1: The shares of Common Stock were purchased by the Reporting Person in an open market transaction. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of Common Stock were purchased by the Reporting Person in an open market transaction.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 28, 2026 Filed Aug 28, 2026 21:01 UTC | BIOVIE INC. BIVI · Entity 7702 | PurchaseCommon Stock | 727 | $2.16 | $1,570.32 |
DisclosureSEC source: 0001520138-26-000382 · ownership.xml · nonDerivative · entry 1 Chappell Amy Suzon · CIK 0002090156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 727 F1 · shares: The shares of Common Stock were purchased by the Reporting Person in an open market transaction. Read SEC document |
| January 05, 2026 Filed Jan 9, 2026 17:00 UTC | BIOVIE INC. BIVI · Entity 7702 | GrantStock Option (right to buy) · Derivative | 57,500 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001520138-26-000018 · ownership.xml · derivative · entry 1 Chappell Amy Suzon · CIK 0002090156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,500 Underlying: Common Stock · 57,500 shares Expires 2031-01-05 F1 · derivative.exercise_date: 7,500 shares underlying the options vest on grant date and the remaining balance will vest in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.